BytePith Health provides authoritative reporting on medical advancements, public health policies, and the science of human wellness. In an era of misinformation, we prioritize evidence-based journalism, covering topics from mental health and nutrition to the latest pharmaceutical breakthroughs and healthcare technologies. Our goal is to empower readers with accurate information to make informed decisions about their well-being and the health of their communities.
At least 40 dead in an active DRC Bundibugyo ebolavirus outbreak. Vaccines built for Zaire strain are ineffective, burial teams have been attacked, and healthcare workers are calling for better protection and security.
The Bundibugyo Ebola outbreak declared a PHEIC in May 2026 now spans 20+ health zones across DRC. With no approved vaccine, active conflict, and community mistrust undermining response operations, the barriers to containment are compounding.
Researchers and food policy scholars say the ultra-processed food crisis mirrors tobacco — same companies, same formulation tactics, same political resistance. Here's what the science and polling show.
The 2026 Bundibugyo Ebola outbreak in DRC and Uganda has confirmed 260+ cases with 1,100 more under investigation. Standard Zaire-strain tools offer limited coverage, and the virus likely spread silently for months before detection.
Daraxonrasib, a targeted oral KRAS inhibitor, extended median overall survival to 14.8–17.2 months in advanced pancreatic cancer, compared to 6–9 months with standard chemotherapy regimens, according to trial data presented at ASCO 2026.
Researchers at Virginia Tech and the University of Tours found that repeated exposure to DEET during feeding trains mosquitoes to treat the repellent's scent as a cue for blood — with implications for how and how often people should reapply.
The ACS updated its colorectal cancer screening guidelines on May 27, 2026, to include Shield, an FDA-approved blood test from Guardant Health, as an option for adults who decline traditional tests.
A rare Bundibugyo ebolavirus outbreak declared a PHEIC in May 2026 has exposed a critical gap: every approved Ebola vaccine and antibody therapy targets the Zaire strain only, leaving responders without proven countermeasures.
A Bundibugyo ebolavirus outbreak declared a PHEIC by WHO in May 2026 has surpassed 900 suspected cases in eastern DRC, with no approved vaccine and containment blocked by war, displacement, and community mistrust.
